Instruction for Authors
Information for Authors
Editors-in-Chief
Professor Dr. med. Thomas Gudermann (Endocrinology)
Professor Dr. med. Peter Nawroth (Diabetology)
Editorial Office
Margret Scherer
Email: margret.scherer@thieme.de
Scope
Experimental and Clinical Endocirnology&Diabetes accepts manuscripts in English in the fields of endocrinology and diabetology from clinical and laboratory research. Special attention is given to obesity, bone metabolism and dyslipidemia. The journal publishes original papers, short communications, reviews, mini-reviews and commentaries. Abstracts from national and international meetings submitted by the organizers will also be considered for publication upon request.
Manuscripts are received with the explicit understanding that they have not been published elsewhere and are not under simultaneous consideration by any other publication.
Manuscript Submission
All manuscripts must be submitted exclusively via online submission at http://mc.manuscriptcentral.com/eced
Submissions of hardcopy manuscripts will not be accepted. Please refrain from sending manuscripts via e-mail. For submission of all manuscripts, please follow the instructions on the online submission system. Before submission, keep ready full metadata of all manuscripts (title, short running title, authors’ names including affiliations and addresses, list of keywords and abstract). The author submitting the manuscript will be corresponding author. Figures should be uploaded separately as *.tif, *.jpg, *.ppt, *.doc or *.xls files (resolution: colored and black-white bitmaps: 300 dpi; diagrams and line drawings: 600 dpi minimum). Tables should be uploaded in a separate Word file (not as a *.jpg file). The legends to the figure and table including Arabic numerals should be entered in the appropriate fields during the file upload. Please note that figures and tables should not be integrated into the main document, but a list with the legends of the figures and tables should be included here. Authors are responsible for the correctness of the manuscripts and the list of references.
A. Original Articles
Original papers should deal with investigations and results of high scientific value which have not been published previously. Authors are asked to follow the outline set below: Page 1: a) title, b) short running title (limit: 40 characters), c) name of the author (no titles or academic grades) and address of the institute(s) where the investigations have been carried out. Should the address of the author at the time of publication differ from the one stated in the paper, the current address should be stated in a footnote, d) complete mailing address of corresponding author including telephone and telefax numbers and e-mail addresses. Page 2: a) an abstract containing not more than 250 words with no abbreviations, b) keywords (3–6 without repeating words in the title). Page 3 and onwards: a) introduction also indicating the aim of the study, b) materials and methods, c) results: double presentation of data in the form of text, tables or figures should be avoided, d) discussion and conclusions, e) list of references, f) legends of tables and figures. Do not include your acknowledgements in the main document but use the appropriate textbox on the online submission system. They will be included in the manuscript upon acceptance for publication. 3. References a) Text: Citations and references should be numbered consecutively using square brackets in the order in which they are cited in the text, followed by any in tables or legends. Please do not number references under alphabetical order of authors. Do not use footnotes and hyperlinks. If authors are mentioned in the text, only the first author should be given followed by “et al.” whenever the reference has three or more authors. Example: “ …protein concentrations were determined according to Lowry et al. [12]. b) List of References: References should be given as plain text. Do not use fields in MS Word, as these are difficult to process later. The references should be listed in numbered order according to the sequence they appear in the text. All authors or groups of authors of each publication should be mentioned. The name of the author(s) should be followed by the full title of the paper, name of the journal in which it has been published (abbreviaions according to Index Medicus viz. PubMed/Medline), year of publication, volume, first and last page. Abstracts and supplements have to be indicated. Chapters from books have to be cited as follows: author(s), title of chapter, title of book, editor(s), place of publication, publisher, year of publication, first and last page of the chapter. Examples:
9 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 193: 265–275
10 Kerner W, Pfeiff er EF. The artificial pancreas. In: Samols E (ed). The endocrine pancreas. New York: Raven Press, 1991: 441–456 B.
Reviews and Mini Reviews Reviews
deal with previous research on a certain topic and serve to summarize current findings on the topic so far. The structure of the review will vary from an original paper according to the nature of the review. Please aim at no more than 20 type-written pages and 100 references. All reviews will be refereed. Please refrain from submitting uninvited reviews. If you plan to submit a review please contact the editors first.
C. Short Communications
Short Communications are completed projects of smaller scope and should contain new clinical and experimental data of immediate interest.
1 They should not exceed 2 printed pages (i.e. 6 type-written double-spaced pages in manuscript 30 lines of 60 letters each) and may include 1 table and 1 figure. The list of references at the end of the paper should not exceed 10 citations.
2 The guidelines for the structure of Short Communications are the same as for Original Articles with following exceptions: a) no keywords and b) no titles of the papers in the list of references.
D. Commentaries
Commentaries are usually invited. They aim at commenting on subjects with a strong impact upon experimental endocrinology and diabetology or they refer to a published article directly.
Clinical Trials Experimental and Clinical Endocirnology&Diabetes supports trial registration. All trials reported must be registered at an official trial registry recognised by the International Committee of Medical Journal Editors, such as ClinicalTrials.gov (www.clinicaltrials.gov) or any of the primary registries on the World Health Organization’s International Clincial Trial Registry Platform (www.who.int/ictrp).
Conflict of Interest
A statement concerning the conflicts of interest of all authors is mandatory.
Copyright
The publishers hold the copyright on all material appearing in Experimental and Clinical Endocrinology&Diabetes. A Copyright Transfer Agreement will be sent to the corresponding author together with the galley proofs. The agreement must be completed and returned to the publishers before the article can be published. If material taken from foreign sources (including figures, etc.) is included in a manuscript submitted to Experimental and Clinical Endocrinology&Diabetes, it must be indicated as such by citation of the original source and, whenever necessary, permission for reproduction must be obtained from the respective publishing company.
English Language
It is in the authors’ best interest that manuscripts be proofread by a native English speaker.
Proofs and Reprints as PDF File
Galley proofs will be sent to the corresponding author as a PDF file. The corresponding author receives a PDF file of the published article free of charge.
Reproduction of Colour Figures
The journal’s fee for colour reproduction amounts to € 440 for the first colour figure and € 80 for any further figure (including 19% VAT).
Research Ethics
For all research involving humans, subjects must have given their informed consent. Research on animals must have been approved by the local ethics committee.

